Federal health officials have approved the first pill to specifically treat postpartum depression.
in 2019, though it isn’t widely used because of its $34,000 price tag and the logistics of administering it.
“I planned my pregnancies, I knew I wanted those kids but I didn’t want to interact with them,” said McMahon, who lives in New York City. She says her mood and outlook started improving within days of taking the first pills.Dr. Kimberly Yonkers of Yale University said the Zurzuvae effect is “strong” and the drug likely will be prescribed for women who haven’t responded to antidepressants. She wasn’t involved in testing the drug.
Sage did not immediately announce how it would price the pill, and Yonkers said that’ll be a key factor in how widely its prescribed.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
First-ever pill for postpartum depression is up for FDA approval this weekThe FDA is expected to decide by Saturday whether to approve the first-ever pill for postpartum depression. If approved, it will become the first treatment that can be taken at home.
Leer más »
First-ever pill for postpartum depression is up for FDA approval this weekThe Food and Drug Administration is expected to decide by Saturday whether to approve the first-ever pill for postpartum depression.
Leer más »
FDA approves first postpartum depression pillFederal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.
Leer más »
First Pill for Postpartum Depression Is Approved by FDAThe pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a recent trial.
Leer más »
FDA approves first postpartum depression pillFederal health officials have approved the first pill specifically intended to treat severe depression after childbirth, a condition that affects thousands of new mothers in the U.S. each year.
Leer más »
FDA approves first-ever pill for postpartum depression in new mothersBiogen and Sage Therapeutics are behind the first FDA-approved pill for treating postpartum depression.
Leer más »